中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共5条，第1-5条 帮助

已选(0)清除 条数/页：   排序方式：
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan;  Zheng, Yabing;  Cao, Wenming;  Chen, Zhanhong
收藏  |  浏览/下载：50/0  |  提交时间：2021/06/15
Metastatic breast cancer (MBC)  treatment  cure  molecular types  targeted therapy  
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载：53/0  |  提交时间：2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring  
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Tian, Yiping;  Sun, Xiaohui;  Cheng, Guoping;  Ji, Enming;  Yang, Shifeng;  Feng, Jianguo;  Zheng, Linfeng
收藏  |  浏览/下载：56/0  |  提交时间：2021/05/17
CMTM6  PD-L1  triple-negative breast cancer (TNBC)  immunohistochemistry (IHC)  polymerase chain reaction (PCR)  prognosis  
Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study 期刊论文
CHINESE MEDICAL JOURNAL, 2012, 卷号: 125
-
收藏  |  浏览/下载：38/0  |  提交时间：2020/10/26
PHASE-III  GROWTH  METAANALYSIS  PLACEBO  RISK  bevacizumab  metastatic breast cancer  angiogenesis  first-line  Chinese  docetaxel  
Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer 期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123
-
收藏  |  浏览/下载：26/0  |  提交时间：2020/10/26
PHASE-III TRIAL  PLUS DOCETAXEL  MULTICENTER  THERAPY  PHOSPHORYLASE  TOLERABILITY  PACLITAXEL  XELODA(R)  SURVIVAL  capecitabine  weekly docetaxel  metastatic breast cancer  anthracycline  elderly  tolerability